Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Intel (INTC) Pops as Tesla Mulls Chip Partnership; Pre‑Market Rebounds on Musk Comments — Nov. 7, 2025

Intel Stock Today (INTC): Price, Layoffs, CPU Cancellation and Conflicting Analyst Calls – November 17, 2025

Published: November 17, 2025 Intel stock (NASDAQ: INTC) is trading in the mid‑$30s today after a flood of fresh headlines – from new layoffs and a reported server CPU cancellation to sharply divergent analyst opinions and hedge‑fund selling. Together, they’re
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron Technology (MU) Stock Today, November 17, 2025: $300 Price Target, AI Memory Breakthroughs and New Highs

Micron Technology’s stock spent Monday, November 17, 2025 trading near record territory as Wall Street hiked price targets, AI-related memory demand stayed red‑hot, and the company highlighted new data‑center and automotive products. By late afternoon, Micron (NASDAQ: MU) was changing
Expedia Group (EXPE) Today: Google AI Partnership, Dividend Deadline and Analyst Upgrades — November 17, 2025

Expedia Group (EXPE) Today: Google AI Partnership, Dividend Deadline and Analyst Upgrades — November 17, 2025

Published: November 17, 2025 Expedia Group, Inc. (NASDAQ: EXPE) is in the spotlight today as investors digest a potent mix of news: a high‑profile partnership with Google’s new AI travel experience, a looming dividend deadline, fresh analyst price‑target hikes and
Microsoft (MSFT) Stock Update & Insight Report – 2 Oct 2025

Microsoft News Today, November 17, 2025: AI Power Crunch, New Copilot Tools, Xbox Showcase and Key EU Rulings

Microsoft enters the week with a dense slate of announcements and headlines touching nearly every part of its business: AI and cloud partnerships, advertising and Copilot features, security updates, Xbox news, EU data‑protection decisions, and even nuclear‑powered data‑centers. Below is
Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

On November 17, 2025, Annovis Bio, Inc. (NYSE: ANVS) released new Phase 3 data in early Parkinson’s disease showing that its lead drug candidate buntanetap halted cognitive decline and improved key Alzheimer’s-related biomarkers in a significant subset of patients. Annovis
1 185 186 187 188 189 552
Go toTop